Elevance Health, Inc.
Elevance Health, Inc. price
About Elevance Health, Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
- Stock ticker
- ELV
- Company
- Elevance Health Inc.
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 12
- Launch date
- Oct 30, 2001
- Listed exchange
- NYSE
Financials
Summary: ELV reported Revenue of 49.83B (+0.82%), beating expectations; EPS of 7.45 (-15.72%), beating expectations.
Dividends
Elevance Health, Inc. conversion tables
 |  |
|---|---|
| 0.5 ELV | 203.03 USD |
| 1 ELV | 406.07 USD |
| 5 ELV | 2,030.39 USD |
| 10 ELV | 4,060.79 USD |
| |
|---|---|
| 0.5 USD | 0.0012313 ELV |
| 1 USD | 0.0024626 ELV |
| 5 USD | 0.012313 ELV |
| 10 USD | 0.024626 ELV |
More to explore
FAQ
ELV is trading at $406.08, +0.44% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ELV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ELV is currently trading at $406.08, +0.44% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ELV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ELV's P/E ratio is currently 17.98 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ELV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ELV's historical range and other companies in the Healthcare sector.
Elevance Health Inc.'s market cap is currently 87.72B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.